Navigation Links
Dr. Renu Razdan of Max Neeman International Appointed Vice Chairman, ACRO India
Date:12/5/2013

RESEARCH TRIANGLE PARK, N.C., Dec. 5, 2013 /PRNewswire/ -- The Association of Contract Research Organizations [ACRO] India has appointed Max Neeman's Chief Operating Officer, Dr. Renu Razdan as Vice Chairman. The appointment is effective immediately with key responsibility to create and strengthen the network with regulatory agencies, law makers and scientific community in India.

Max Neeman, a leading Indian provider of clinical research services to the pharmaceutical, biotech and medical device industry for over 10 years, promoted Dr. Razdan to COO in 2009. Prior to joining the company, she worked at Ranbaxy Laboratories Limited as Senior Manager Business Development then Head of Exports, and has also worked with Transasia Biomedicals and HPCL Systems.

Dr. Razdan holds a PhD in Biochemistry from German Cancer Research Centre (DKFZ), Heidelberg, Germany and has been featured as a prominent female achiever in the Life Sciences community; November 2010 issue of 'BioSpectrum India' life science journal.

When asked what she hopes to achieve, Dr. Razdan's response was twofold: 1) to strengthen the channels of communication between industry, regulators and other stakeholders for drug development in India 2) focus on promoting India as a place where good drug development research takes place, despite recent challenges.

About Max Neeman International
'Max Neeman' is a leading Asia-Pacific CRO with India expertise and expanded capabilities into N. America and Europe. Since 2001, the company has provided clinical research services for the successful conduct of drug and device trials in compliance with ICH GCP standards. The company is ISO 9001:2008 certified for monitoring, site management and data management with over >400 employees, 245 active sites in various therapeutic areas and 310 trials awarded. Data Management services alone have touched 60 countries. For more information contact Donald Swankie, Vice President USA:  919.424.3345, donald.swankie@neeman-medical.com or go to www.neeman-medical.com.

About ACRO
ACRO is an independent, non-profit organization with a global perspective. ACRO India, founded and registered in India in Feb 2005, has been formed under the aegis of Confederation of Indian Industry (CII) for bringing all CRO's operating in India on one common platform. With its vision of establishing India as a global sourcing hub for Contract Research, ACRO is used to promote quality research, uphold ethics, share best practices, promote synergies amongst members, to deliberate and act upon common concerns, especially with regards to Indian regulations and industry environment.


'/>"/>
SOURCE Max Neeman International
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. UV Flu Technologies Expands Its International Footprint
2. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
3. International Attendance for Networking and Education at Informex Beyond Manufacturing
4. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
5. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
6. First Free-Standing International Mesothelioma Research Laboratory Opens in Los Angeles
7. PAREXEL International to Present at J.P. Morgan Healthcare Conference
8. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform: NursingChina.com
9. Senior Management of NeoStem and Its Subsidiaries Invited to Speak at Seventh International Conference on Cell Therapy for Cardiovascular Disease
10. First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration
11. BioRestorative Therapies to Present at 7th International Conference on Cell Therapy for Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , March 27, 2017 Neurotrope, Inc. ... therapies for neurodegenerative diseases, including Alzheimer,s disease, today ... application to list the Company,s common stock on ... The NASDAQ Stock Market, a unit of the ... will ring the Opening Bell at the NASDAQ ...
(Date:3/24/2017)... Research and Markets has announced the addition ... Strategic Business Report" report to their offering. ... This report analyzes the Global ... Annual estimates and forecasts are provided for the period 2014 through ... research. The report profiles 25 companies including many ...
(Date:3/24/2017)... , March 24, 2017   Sienna Biopharmaceuticals, Inc. ... company, today announced that Richard Peterson will ... 24.   Peterson, who brings more than two ... Smither , who is retiring at the end of ... advisory capacity. Peterson joins Sienna from Novan, Inc., where ...
(Date:3/23/2017)... ... , ... Lajollacooks4u is proud to announce it has become the premiere team-building cooking event company ... around the world, such as Illumina, HP and Qualcomm, and is ranked #1 in its ... is due to its new team building format, a way for teams to not only ...
Breaking Biology Technology:
(Date:2/27/2017)... , Feb. 27, 2017   Strategic Cyber Ventures ... it has led a $3.5 million investment in  Polarity ... Strategic Cyber Ventures is DC based and is led ... Hank Thomas . Ron Gula , also a ... also participated in this series A round of funding. ...
(Date:2/22/2017)... , Feb. 22, 2017 With the ... ABI Research identifies four technologies that innovative and ... secure significant share in the changing competitive landscape: ... passive authentication.   "Companies can no ... to security," says Dimitrios Pavlakis , Industry ...
(Date:2/16/2017)... SAN FRANCISCO , Feb. 16, 2017 /PRNewswire/ ... research, today announced that it has received Laboratory ... The CAP Accreditation is presented to laboratories that ... and who demonstrate scientifically rigorous processes. ... of excellence in laboratory practices. We,re honored to ...
Breaking Biology News(10 mins):